👉Novo Nordisk's weight-loss drug Wegovy, similar to Ozempic but at a higher dose of semaglutide, will be available in Canada starting May 6. Health Canada approved Wegovy in November 2021 for patients with obesity or those significantly overweight with weight-related medical conditions. Dr. Sanjeev Sockalingam of Obesity Canada emphasizes Wegovy as a crucial treatment for obesity, not for cosmetic purposes. It's to be used alongside physical activity and nutrition. Wegovy's arrival follows extensive marketing of Ozempic and off-label use for weight loss. Prescribers must ensure it's given to eligible patients only.✅ . 𝐀𝐮𝐠𝐮𝐬𝐭𝐢𝐧𝐞 𝐉𝐨𝐲 𝐓𝐚𝐱 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥 @taxesatjoy @augustine.joy_ 𝙎𝙩𝙪𝙙𝙚𝙣𝙩 𝙎𝙪𝙥𝙥𝙤𝙧𝙩 𝙉𝙚𝙬𝙘𝙤𝙢𝙚𝙧𝙨 𝘼𝙨𝙨𝙞𝙨𝙩𝙖𝙣𝙘𝙚 𝘽𝙪𝙨𝙞𝙣𝙚𝙨𝙨 𝙏𝙖𝙭 𝙨𝙤𝙡𝙪𝙩𝙞𝙤𝙣𝙨 𝙎𝙢𝙖𝙡𝙡 𝘽𝙪𝙨𝙞𝙣𝙚𝙨𝙨 𝘾𝙤𝙧𝙥𝙤𝙧𝙖𝙩𝙞𝙤𝙣𝙨 𝘼𝙪𝙙𝙞𝙩𝙞𝙣𝙜 𝙍𝙚𝙥𝙧𝙚𝙨𝙚𝙣𝙩𝙖𝙩𝙞𝙤𝙣 +𝟏 𝟑𝟎𝟔 𝟑𝟏𝟑 𝟔𝟗𝟖𝟗 𝐭𝐚𝐱𝐞𝐬𝐚𝐭𝐣𝐨𝐲@𝐠𝐦𝐚𝐢𝐥.𝐜𝐨𝐦 𝐰𝐰𝐰.𝐭𝐚𝐱𝐞𝐬𝐚𝐭𝐣𝐨𝐲.𝐜𝐚 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 𝐥𝐨𝐜𝐚𝐭𝐢𝐨𝐧: 𝐀𝐥𝐥 𝐨𝐯𝐞𝐫 𝐂𝐚𝐧𝐚𝐝𝐚 𝐞𝐱𝐜𝐞𝐩𝐭 𝐐𝐮𝐞𝐛𝐞𝐜 . . #Wegovy #WeightLoss #ObesityTreatment #HealthCanada #NovoNordisk #MedicalNews #CanadianHealthcare #mnm #malayalisnearmeapp #canadaupdate #canadanews